MedTrace Logo

Treatment of Leg Telangiectasias With Nd:YAG 1064nm

NCT01118390 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2010-05-06

No results posted yet for this study

Summary

Studying the results of treatment of dilated vessels of the lower limbs with laser, and compare them to those obtained with sclerotherapy.

Conditions

  • Telangiectasias

Interventions

DEVICE

Laser Nd:YAG 1064nm

Patients with leg telangiectasias are treated with 3 sessions of Nd:YAG 1064nm, with 14 days interval

OTHER

Sclerotherapy

Patients with leg telangiectasias are treated with 3 sessions of sclerotherapy, with 14 days interval

Sponsors & Collaborators

  • Grupo de Cirurgia Vascular

    lead OTHER

Principal Investigators

  • Nelson Wolosker, MD, PhD · Hospital das Clinicas, University of Sao Paulo

  • Marco Munia, MD · Hospital das Clinicas, University of Sao Paulo

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-08-31
Primary Completion
2010-03-31
Completion
2010-07-31

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01118390 on ClinicalTrials.gov